Hanna Sartor

Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study

Kristina Lång, Viktoria Josefsson, Anna-Maria Larsson et al. · The Lancet Oncology · 2023 · 434 citations · Full text

Artificial Intelligence, Engineering, Medical Imaging +12

One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study

Sophia Zackrisson, Kristina Lång, Aldana Rosso et al. · The Lancet Oncology · 2018 · 175 citations

Medical Imaging, Cancer Screening, Medicine +8

Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study

Veronica Hernström, Viktoria Josefsson, Hanna Sartor et al. · The Lancet Digital Health · 2025 · 73 citations · Full text

Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening

Mikael Eriksson, Kamila Czene, Fredrik Strand et al. · Radiology · 2020 · 72 citations · Full text

An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

Artur Mezheyeuski, Max Backman, Johanna Sofia Margareta Mattsson et al. · EBioMedicine · 2023 · 72 citations · Full text